15th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Zydus Lifesciences received USFDA approval for colestipol hydrochloride tablets Zydus Lifesciences Ltd. has gained final approval from the US…
PharmaState Updates – Latest Pharma Happenings Zydus Lifesciences received USFDA approval for colestipol hydrochloride tablets Zydus Lifesciences Ltd. has gained final approval from the US…
H2H Marketing follows a highly integrative and collaborative approach. Therefore, a pharma brand cannot be viewed separately but rather it must be integrated into the…
What is marketing? The Grand Guru of Marketing, Philip Kotler says: “First – Identify and define a human problem; a real problem. Then find a…
Have you heard about the book “Firms of Endearment” written by Raj Sisodia, Jagdish Sheth, and David Wolfe? Firms of Endearment write the authors, are…
PharmaState Updates – Latest Pharma Happenings USFDA makes three observations on Zydus’ Jarod manufacturing unit Following an examination of its Jarod (Vadodara) manufacturing facility, Zydus…
PharmaState Updates – Latest Pharma Happenings Sanofi Receives CDSCO Approval to Study Dupilumab The drug major has received a nod from a committee of the…
PharmaState Updates – Latest Pharma Happenings Sanofi Receives CDSCO Approval to Study Dupilumab The drug major has received a nod from a committee of the…
Case Study – Why doctors are averse to ‘new products’? Praveen and Naveen, the brand managers at V & V Pharmaceuticals were discussing the launch…
PharmaState Updates – Latest Pharma Happenings The combination of Covishield and Covaxin improves immunity: ICMR A study conducted by ICMR discovered that combining the two…
PharmaState Updates – Latest Pharma Happenings Medtronic Introduces the MiniMed 780G System with SmartGuard Technology in India to Simplify Type 1 Diabetes Management Automatic insulin…
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.
You must be logged in to post a comment.